Use of Drug Sensitisers to Improve Therapeutic Index in Cancer
The clinical management of malignant tumours is challenging, often leading to severe adverse effects and death. Drug resistance (DR) antagonises the effectiveness of treatments, and increasing drug dosage can worsen the therapeutic index (TI). Current efforts to overcome DR predominantly involve the...
Saved in:
Main Authors: | Yu-Shan Chen (Author), Enhui Jin (Author), Philip J. Day (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy
by: Elena Andreucci, et al.
Published: (2019) -
Human Vulnerability to Depleting Water Resources in Cameroon: Sensitisation approaches
by: Samuel N. Ayonghe, et al.
Published: (2007) -
Epidemiological consequences of immune sensitisation by pre-exposure to vector saliva.
by: Tsukushi Kamiya, et al.
Published: (2017) -
Need to investigate COVID-19 beliefs for tailor-made sensitisation campaigns
by: Marie Chan Sun, et al.
Published: (2021) -
Therapeutic index improvement of antibody-drug conjugates
by: Hans-Peter Gerber, et al.
Published: (2023)